Global Cell Therapy Technologies Market Share to Reach $9.87 Billion by 2029, Growing at 14.9% CAGR

What market dynamics are playing a key role in accelerating the growth of the cell therapy technologies market?
The worldwide market for cell therapy technologies is experiencing growth due to the heightened governmental investments in cell-based research. Research activities aimed at creating therapies for diseases such as cancer, cardiovascular disease (CVD), among others are receiving increased governmental funding. An example of this is the California Institute for Regenerative Medicine (CIRM), a stem cell research support center. In May 2022, they invested over $11 million in a clinical trial for a cell therapy targeting throat cancer. The successful development of this therapy could eliminate the need for patients to undergo radiotherapy and avoid its associated side effects.

Get Your Cell Therapy Technologies Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

How will the growth rate of the cell therapy technologies market shape industry trends by 2034?
In recent years, the market size of cell therapy technologies has seen a significant surge. The market is projected to expand from $4.92 billion in 2024 to $5.67 billion in 2025, recording a compound annual growth rate (CAGR) of 15.4%. This substantial growth over the historic period may be linked to robust economic progress in developing markets, heightened healthcare spending, augmented government investments in cell-based research, and a rising demand for tailor-made medicine.

In the upcoming years, the cell therapy technologies market is anticipated to experience swift expansion. The market is projected to reach $9.87 billion by 2029, with a compound annual growth rate (CAGR) of 14.9%. This growth during the forecast period is likely due to factors such as an increasing aging population, a rise in cancer prevalence, heightened investment in research and development within the pharmaceutical industry, and cell therapy breakthroughs. Key trends in this forecast period encompass innovation in product creation, incorporation of advanced technologies, the development of pioneering cell therapies, capital investment in production facilities, as well as strategic partnerships and collaborations.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What trends are poised to drive the future success of the cell therapy technologies market?
Leading businesses in the cell therapy technologies market are innovating and leveraging cutting-edge technologies to expand their presence. For example, Invetech, an Australian firm specializing in the creation, engineering, and production of diagnostic goods and cell and gene therapies, unveiled a revolutionary product named Korus in June 2022. This unique closed system developed specifically for autologous cell therapies is designed to revolutionize elutriation and cell wash industry standards. The technology implements a gentle elutriation procedure to provide a purer cell group for cell therapy manufacturing procedures, including tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cell, or induced pluripotent stem cell (IPSC)-derived therapy. Korus utilizes gentle counterflow centrifugation for elutriation and cell wash, supplying purified cell populations for further processing development and commercial production. This will enhance the effectiveness of processes by increasing the recovery and purity of target cells. With the introduction of Korus, developers can accelerate the clinical development and scaling up of their products.

Which primary segments of the cell therapy technologies market are driving growth and industry transformations?
The cell therapy technologies market covered in this report is segmented -

1) By Product: Consumables, Equipment, Systems And Software
2) By Cell Type: T-Cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control
4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:
1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials
2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators
3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4122

Which geographical regions are pioneering growth in the cell therapy technologies market?
North America was the largest region in the cell therapy technologies market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the cell therapy technologies market landscape?
Major companies operating in the cell therapy technologies market include Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Is Covered In The Cell Therapy Technologies Global Market Report?

•Market Size Forecast: Examine the cell therapy technologies market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the cell therapy technologies market for a structured understanding.
•Key Players Overview: Analyze major players in the cell therapy technologies market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell therapy technologies market.
•Segment Contributions: Evaluate how different segments drive overall growth in the cell therapy technologies market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell therapy technologies market.
•Industry Challenges: Identify potential risks and obstacles affecting the cell therapy technologies market.
•Competitive Landscape: Review strategic developments in the cell therapy technologies market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.